Prevenar 13 (0.5ml) pneumococcal vaccine

Pneumococcal infection is an acute bacterial infection that can cause various diseases. Most often, the causative agent of pneumococcal infection causes pneumonia, but it can also be the cause of meningitis, angina, endocarditis (a disease caused by a bacterial or fungal lesion in the inner layer of the heart (endocardium) or heart valves), and other diseases, depending on the location of the infectious process. Pneumococci are one of the most common causes of pneumonia and middle ear infections.

These bacteria can be found in the nasopharynx of completely healthy people. The pathogen spreads through airborne droplets, and when it enters the lower respiratory tract of a person, it multiplies, leading to respiratory tract inflammation. People with chronic diseases and weakened immunity are at higher risk of getting sick. Illness can also occur due to unfavorable external factors: colds, overwork, stressful situations, viral upper respiratory tract infections, and more.

Vaccines are the most effective means of protection against pneumococcal infection.

Clinical information about the Prevenar 13 vaccine
The vaccine is intended to protect infants from 6 weeks, children, and adults from diseases caused by pneumococci.
It is recommended to inject the vaccine into the muscle of the arm or thigh.

COVID-19 and pneumococcal vaccine
The World Health Organization (WHO) recommends getting vaccinated against pneumococcal infection in the presence of coronavirus infection risk to reduce the risk of complications caused by the virus.